Courtney D. DiNardo

Sanam Loghavi: Cytomolecular Drivers of Relapse After Frontline FLT3 Inhibitor Therapy in FLT3-Mutated AML

Sanam Loghavi: Data-Driven Insights Refine Myeloid Neoplasm Classification

Sanam Loghavi: Relapse Patterns in NPM1-Mutated AML After Venetoclax-Based Therapy

Vincent Rajkumar Highlights New Guidance for Managing AML in the Elderly Patients

Naveen Pemmaraju: Novel Tasquinimod-Based Combos in Advanced MPNs

Naseema Gangat: Recent Advances in AML Treatment for Unfit Patients

Indraneel Deshmukh: Important data in FLT-3 TKD Mutated AML

Naveen Pemmaraju: Prognostic Impact of NPM1 Co-Mutation in FLT3-Mutated AML

Naveen Pemmaraju: Outcomes of Octa‐Nonagenarians with Newly Diagnosed Acute Myeloid Leukemia

Jayastu Senapati: Contemporary Outcomes of Octa‐Nonagenarians with ND-AML